MP78-01 IMPACT OF URETEROSCOPY BEFORE RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMAS ON ONCOLOGIC OUTCOMES: A META-ANALYSIS
Run‐Qi Guo,Hong Peng,Xuesong Li,Liqun Zhou
DOI: https://doi.org/10.1016/j.juro.2017.02.2089
IF: 7.6
2017-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyBladder Cancer: Upper Tract Transitional Cell Carcinoma II1 Apr 2017MP78-01 IMPACT OF URETEROSCOPY BEFORE RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMAS ON ONCOLOGIC OUTCOMES: A META-ANALYSIS Run-Qi GUO, Peng HONG, Xue-Song LI, and Li-Qun ZHOU Run-Qi GUORun-Qi GUO More articles by this author , Peng HONGPeng HONG More articles by this author , Xue-Song LIXue-Song LI More articles by this author , and Li-Qun ZHOULi-Qun ZHOU More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2089AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In the current era, the ureteroscopy (URS) has become a powerful tool to diagnose and treat patients with upper tract urothelial carcinoma (UTUC). However, there is concern that it may have a negative impact on the patients. We aim to investigate whether the URS before RNU for UTUC has impact on oncologic outcomes. METHODS We performed a systematic literature search of PubMed, Embase, and Cochrane library for citations published prior to June 2016, describing URS performed among patients with UTUC and conducted a standard meta-analysis of survival outcomes. RESULTS Our meta-analysis included eight eligible studies containing 2998 patients. The results were as follows: cancer-specific survival(CSS) (Hazard Ratio(HR) = 0.74, 95% confidence interval(CI): 0.59-0.94, P = 0.01), overall survival(OS) (HR = 0.76, 95% CI: 0.48-1.21, P = 0.24), recurrence-free survival(RFS) (HR = 0.89, 95%CI: 0.69-1.14, P = 0.37), metastasis-free survival(MFS) (HR = 1.06, 95% CI: 0.82-1.36, P = 0.66), and intravesical recurrence-free survival(IRFS) (HR = 1.54, 95% CI: 1.31-1.80, P < 0.00001). Besides, excluding the previous bladder tumor history, the results of IRFS were HR = 1.83, 95% CI: 1.55-2.15, and P < 0.00001. CONCLUSIONS This meta-analysis indicated that URS before RNU did not have a negative impact on CSS, OS, RFS and MFS in UTUC patients. However, patients are at higher risk for intravesical recurrence after RNU when they have undergone prior URS. Further studies are needed to assess the effects of post-URS intravesical chemotherapy on intravesical recurrence. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1030 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Run-Qi GUO More articles by this author Peng HONG More articles by this author Xue-Song LI More articles by this author Li-Qun ZHOU More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...